Skip to content
Open access · CC-BY via OpenAlex

Therapeutic interventions for aging: the case of cellular senescence

Abel Soto-Gamez, Marco Demaria

Drug Discovery Today · 2017 · ▲ 194 citations

Abstract

Organismal aging is a multifactorial process characterized by the onset of degenerative conditions and cancer. One of the key drivers of aging is cellular senescence(definition), a state of irreversible growth arrest induced by many pro-tumorigenic stresses. Senescent cells accumulate late in life and at sites of age-related pathologies, where they contribute to disease onset and progression through complex cell and non-cell autonomous effects. Here, we summarize the mechanisms by which cellular senescence can promote aging, and we offer an extensive description of current potential pharmacological interventions for senescent cells, highlighting limitations and suggesting alternatives.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.drudis.2017.01.004
Canonical
link ↗
Fetched
2026-08-03 MST

Cite this

APA
Soto-Gamez, A., &amp; Demaria, M. (2017). Therapeutic interventions for aging: the case of cellular senescence. <em>Drug Discovery Today</em>. https://doi.org/10.1016/j.drudis.2017.01.004
Vancouver
Soto-Gamez A, Demaria M. Therapeutic interventions for aging: the case of cellular senescence. Drug Discovery Today. 2017. doi:10.1016/j.drudis.2017.01.004.
BibTeX
@article{abel2017Therap, title = {Therapeutic interventions for aging: the case of cellular senescence}, author = {Abel Soto-Gamez and Marco Demaria}, journal = {Drug Discovery Today}, year = {2017}, doi = {10.1016/j.drudis.2017.01.004}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings